Cart 0

Our Board & Advisors


Our Board Members


Kevin Didden


Kevin has spent the last 20 years as the Founder and CEO of CiDRA, a trusted process optimization company to many of the largest companies in the world. He has served as Chairman of the Board at three companies, in addition to CytoVeris.

Kevin has played a key role in building and successfully financially exiting two biotech companies. The first was CyVera, which was launched in 2003 and then sold to the gene sequencing market leader Illumina in 2005. The second was CyVek, which was launched in 2011 and then sold to Bio-Techne in 2016.

Kevin received a BS degree in Business Administration from the University of Connecticut and an MBA from the Rensselaer Polytechnic Institute.



Michael Grillo

Mike Grillo is an attorney with venture capital, corporate finance and transactional experience. Prior to joining CiDRA, Mike focused on Intellectual Property protection, technology management and licensing with a private law firm and with a fortune 100 company.

Mike received a Bachelors Degree in Electrical Engineering from the University of Delaware and a JD from the University of Connecticut School of Law.



Alan Kersey

Alan has been involved in optical fiber sensing, optical instrumentation and biotech tools development and systems commercialization through start-ups in Connecticut for over 20 years. In 1997, Alan was the founding CTO with CiDRA in Wallingford, CT. In 2003, he became CEO at CyVera Corp, which was a spin-out from CiDRA focused on the development of an innovative liquid assay for genomic and proteomic analysis using a novel holographically encoded micro-bead technology. Following the acquisition of CyVera by Illumina in 2005, Alan served as Vice President and General Manager with Illumina for their UK group based in Cambridge. Currently he is also a partner with Cycle Ventures, a CT-based venture capital group.

Alan’s scientific background is in optical instrumentation, optical fiber sensing and spectroscopy. He is a prolific inventor and holds over 120 US patents.

He has a BS in Physics from the University of Warwick, and a Ph.D. in Optical Spectroscopy and Medical Physics from the University of Leeds, both in the UK.